Stockscreener 앱 받기
1.389
0.79%
-0.011
Sunshine Biopharma Inc (SBFM) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
5.72%
9.4102
|
8.9013 | 9.595 | 8.4352 | 9.3031 |
| Cost Of Revenue |
2.97%
5.9874
|
6.1709 | 6.5019 | 5.569 | 6.9468 |
| Gross Profit |
25.36%
3.4229
|
2.7304 | 3.093 | 2.8662 | 2.3563 |
Operating Expenses
|
36.05%
5.4775
|
4.0262 | 5.1308 | 3.9725 | 3.6245 |
| Benefits Costs and Expenses |
12.54%
11.39
|
10.12 | 11.88 | 9.4178 | 10.14 |
| Costs And Expenses |
12.54%
11.39
|
10.12 | 11.88 | 9.4178 | 10.14 |
| Operating Income/Loss |
58.57%
-2.0547
|
-1.2958 | -2.0377 | -1.1064 | -1.2683 |
| Nonoperating Income/Loss |
1.53%
0.0747
|
0.0758 | -0.2492 | 0.1238 | 0.4303 |
| Income/Loss From Continuing Operations Before Tax |
62.30%
-1.98
|
-1.2199 | -2.2869 | -0.9826 | -0.838 |
| Income Tax Expense/Benefit |
420.82%
-0.2092
|
-0.0402 | -0.1287 | 0.2152 | -0.3437 |
| Income/Loss From Continuing Operations After Tax |
50.10%
-1.7708
|
-1.1798 | -2.1582 | -1.1978 | -0.4943 |
|
Net Income/Loss
|
50.10%
-1.7708
|
-1.1798 | -2.1582 | -1.1978 | -0.4943 |
| Preferred Stock Dividends And Other Adjustments |
1.1798
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
66.32%
4.4961
|
2.7033 | 0.4831 | 1.2676 | 0.0497 |
| Diluted Average Shares |
33.34%
3.6047
|
2.7033 | -1.2569 | 1.2676 | 0.0497 |
| Basic Earnings Per Share |
11.36%
-0.39
|
-0.44 | 6.29 | -0.94 | -9.94 |
| Diluted Earnings Per Share |
86.36%
-0.82
|
-0.44 | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
1.1798
|
- | - | - | - |
0.21%
0.76%
자본화:
|
볼륨(24시간):